NI, Thanks for the post. My take on the release is that O'Shea knows
he needs a spokesman eminently qualified in the trans-dermal/alter-
native vaccination area. Mr DeWeese sure fits the bill. His presence will bolster confidence of major drug manufacturers. Sounds like Rick Plestina is more the money-capital man.
Several quarters ago I learned that the company was negotiating with a "major health care products company in the mid-west" with a sales force of several hundered to handle distrubution of the product. It sure would make a difference because BJCT has a sales force of six. After the news on Abbott broke I figured the whale got away. Maybe not. Maybe Baxter is the "major health care products company"; but whatever, having DeWeese on the board to coach the team will be sure to help.
Here's an interesting link to a packaged intravenous drug delivery system offering hospitals similar advantages in IV applications that BJCT offers clinics in vacination applications.
(tried a link but got an expired message)
Source: Wyeth-Ayerst Laboratories
Wyeth-Ayerst Laboratories Announces New, Convenient Delivery System For ZOSYN(R)
Granted Marketing Clearance By the FDA
RADNOR, Pa., June 26 /PRNewswire/ -- Wyeth-Ayerst Laboratories, a division of American Home Products Corporation (NYSE:AHP), announced today that
it has received clearance by the U.S. Food and Drug Administration (FDA) to market the fastest-growing established I.V. antibiotic, ZOSYN(R) (piperacillin
sodium/tazobactam sodium), in the Abbott Add-Vantage(R) intravenous drug delivery system.
As in the original formulation, ZOSYN combines piperacillin, a broad spectrum antibiotic, with tazobactam, one of the most active beta-lactamase inhibitors.
ZOSYN is currently used in nearly 4,000 hospitals in the United States.
The Abbott Add-Vantage drug delivery system is a proprietary I.V. admixture system used by over 2,500 U.S. hospitals. Hospitals select the Abbott system for several reasons including decreased pharmacist mixing time and decreased drug waste. For these reasons, pharmacists have been eagerly awaiting the new ZOSYN packaging.
NOTE: Add-Vantage is a registered trademark of Abbott Laboratories.
I'll try to post some background links this wkend.
best art |
